News section
home news forum careers events suppliers solutions markets resources directories advertise contacts search site plan
 
.
Origin Agritech Limited reports third quarter FY08 results

.

Beijing, China
August 28, 2008
 
  • Revenues increased 7.73% to RMB 490.71 million from RMB 455.49 million
  • Gross profit rose 32.29% to RMB 144.09 million from RMB 108.92 million
  • Income from Operations rose 65.77% to RMB 98.38 million from 59.35 million
  • Net income increased 62.98% to RMB 60.12 million from RMB 36.89 million
  • Fully diluted EPS increased 74.67% to RMB 2.62  from RMB 1.50

Origin Agritech Limited (NASDAQ: SEED) (“Origin” or the “Company”), a technology-focused supplier of crop seeds in China, today announced unaudited financial results for the third quarter ended June 30, 2008. Origin prepares its financial statements in accordance with generally accepted accounting principles (GAAP) of the United States.

Financial Results Overview

During the third quarter of fiscal 2008, the Company generated revenues of RMB 490.71 million (US$71.54 million), an increase of 7.73% from revenue of RMB 455.49 million (US$59.84 million) for the three months ended June 30, 2007. This was mainly due to a 6.2% increase in the average sales price of our products across all seed types with volumes also increasing 2.2%.

Corn revenues increased 7.75% year-over-year to RMB 366.04 million (US$53.37 million) from RMB 339.72 million (US$44.63 million). This was mainly due to a 10.25% increase in the average sales price of our products across corn seed types.

Gross margins for the third quarter improved to 29.36%, as compared to 23.91% achieved during the third quarter of 2007 caused by an increase in the average selling price.

Total operating expenses for the three months ended June 30, 2008 were RMB 45.71 million (US$6.66 million), a decrease of 7.79% from RMB 49.58  million (US$6.51 million) in the same period of the prior year. The decrease was mainly due to the effective internal controls over daily operating costs and expenses.

  • Selling and marketing expenses were RMB 16.82 million (US$2.45 million) for the third quarter of 2008, representing a decrease of 7.95% from RMB 18.27 million (US$2.40 million) for the same period of the last year, which was mainly due to the decrease in advertising expenses.  Our marketing focus this year consisted mainly of setting up more effective and cost efficient field demonstration lots, and eliminating our spending on advertising and other media expenditures. 
  • General and administrative expenses of RMB 19.06 million (US$2.78 million) for the third quarter ended June 30, 2008, decreased 4.29% from RMB 19.92 million (US$2.62 million) for the three months ended June 30, 2007 due to an effective control over daily operating costs and expenses, which should continue to take further effect over the next 3 quarters.
  • Research and development expenses during the quarter were RMB 9.83 million (US$ 1.43 million), as compared with RMB 11.39 million (US$ 1.50 million) for the three months ended June 30, 2007. R&D expenditures decreased slightly this quarter, but it has increased for the nine-month period as a result of the increased build out of our in-house biotechnology center at our Beijing headquarters.  We expect to continue building our capabilities in an efficient, cost effective manner. 

Income from operations for the third quarter of 2008 amounted to RMB 98.38 million (US$ 14.34 million) compared with an operating income of RMB 59.35 million (US$7.80 million) in the same period in 2007 reflecting a 65.77% increase year-over-year.

Interest expenses for the third quarter of 2008 were RMB10.31 million (US$1.50 million), representing an increase of 145.29 % from RMB 4.20 million (US$0.55 million) for the three months ended June 30, 2007, which was primarily attributable to the inclusion of the interest expenses on the convertible debt of RMB 5.51 million (US$0.80 million) in the third quarter of 2008.

Net income for the third quarter of 2008 rose by 62.98% to RMB 60.12 million (US$ 8.77 million), as compared to net income of RMB 36.89 million (US$4.85 million) in the same period a year ago.  Earnings per share on a fully diluted basis were RMB 2.62 (US$0.38), as compared to RMB 1.50 (US$0.20) per diluted share in the same period one year ago, reflecting a 74.67% year-over-year increase.

Balance Sheet

As of June 30, 2008 and September 30, 2007, Origin's balance sheet included cash and cash equivalents of RMB 334.66 million (US$48.79 million) and RMB162.31 million (US$21.66 million), respectively. Investments in US Government Agency bonds amounted to RMB 12.57 million (US$1.83 million) and RMB 133.97 million (US$17.88 million), respectively. Net working capital amounted to RMB 285.96 million (US$ 41.69 million) and RMB 294.98 million (US$39.37 million), respectively. Total shareholders' equity increased to RMB 332.38 million (US$48.46 million) as compared to RMB 296.92 million (US$39.63 million) for September 30, 2007.

Company Update

As the Company moves beyond the 2007 transition year, the average prices, exclusive of scrap sales, have rebounded and increased year-over-year by approximately 6.2%.  Volume has also increased 2.2%. In addition to the growth due to the reversal of industry factors, the Company has also streamlined its marketing efforts. The lower sales and marketing expense was due to a focus on more effective on-site demonstration lots for the Company’s customer base, yielding higher average price and volumes.  The Company intends to increase its efforts in this regard, by doubling the demonstration lots in FY2008 from 5,000 to 10,000 in FY2009. 

Origin also entered into a Notes Repurchase Agreement on July 28, 2008  with Citadel Equity Fund Ltd. providing for the repurchase by the Company from Citadel of a portion of the Company’s outstanding 1% Guaranteed Senior Secured Convertible Notes due 2012. The Note repurchase provides Origin with the opportunity to increase equity shareholder value while providing flexibility to its operations as well as fund its GMO development through internally generated resources.

GMO Pipeline Update

During the quarter, Origin submitted to the Ministry of Agriculture (MOA) its final application and all related documents regarding the Phytase corn product. The Company is hopeful a final decision will be rendered before the end of this year. Upon approval, the product would be able to be sold into the Chinese marketplace. This would mark the first GMO corn product approved for commercialization in China. 

Revenue Guidance

Origin expects that total revenues for the year ending September 30, 2008 will approximate US$75 - US$80 million. Net income for the year ending September 30, 2008 will approximate US$0.5 - US$2.0 million.

The net income figure is inclusive of roughly US$ 2.65 million dollars in non-cash interest expense from our convertible debt offering. Excluding this non-cash expense, the adjusted net income range would be US$3.0 to US$4.5 million. The Company plans to release guidance for 2009 by FY08 year end.  

Founded in 1997 and headquartered in Beijing, Origin Agritech Limited (NASDAQ: SEED) is one of China’s leading, vertically-integrated agricultural technology company specializing in agri-biotech research, development and production to supply the growing populations of China.  Origin develops, grows, processes, and markets crop seeds to farmers throughout China and parts of Southeast Asia via a network of approximately 3,800 first-level distributors and 65,000 second-level distributors and retailers.  The hybrid seed industry is estimated at US$2 billion and that is expected to double by 2010.  The Company currently operates facilities in 30 of China’s 32 provinces as well as Beijing.  Since Origin launched its first entirely internally developed seed in 2003, the Company has developed and commercialized an internally developed proprietary seed portfolio of twelve corn hybrids, twelve rice hybrids and two canola hybrids as of 2007. 

CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except number of share and per share data)
 

 

 

Three months ended June 30,

 

 

2007

 

2007

 

2008

 

2008

 

 

RMB

 

US$

 

RMB

 

US$

 

 

(unaudited)

 

(unaudited)

 

(unaudited)

 

(unaudited)

 

 

 

 

 

 

 

 

 

Revenues

 

455,486

 

59,838

 

490,709

 

71,541

Cost of revenues

 

(346,565)

 

(45,529)

 

(346,616)

 

(50,534)

 

 

 

 

 

 

 

 

 

Gross Profit

 

108,921

 

14,309

 

144,093

 

21,007

 

 

 

 

 

 

 

 

 

Operating expenses:

 

 

 

 

 

 

 

 

Selling and marketing

 

(18,272)

 

(2,400)

 

(16,819)

 

(2,452)

General and administrative

 

(19,918)

 

(2,617)

 

(19,063)

 

(2,779)

Research and development

 

(11,386)

 

(1,496)

 

(9,832)

 

(1,433)

 

 

 

 

 

 

 

 

 

Total operating expenses

 

(49,576)

 

(6,513)

 

(45,714)

 

(6,664)

 

 

 

 

 

 

 

 

 

Profit from operations

 

59,345

 

7,796

 

98,379

 

14,343

Interest expense

 

(4,201)

 

(552)

 

(10,305)

 

(1,502)

Share of earnings in equity investee companies

 

9,170

 

1,205

 

3,398

 

495

Interest income

 

2,044

 

268

 

873

 

127

Other income

 

74

 

10

 

97

 

14

Changes in the fair value of embedded derivatives

 

-

 

-

 

(2,752)

 

(401)

 

 

 

 

 

 

 

 

 

Profit before income taxes and minority interests

 

66,432

 

8,727

 

89,690

 

13,076

Income tax expense

 

 

 

 

 

 

 

 

Current

 

(5,612)

 

(737)

 

(7,210)

 

(1,051)

Deferred

 

(6,745)

 

(886)

 

(7,488)

 

(1,092)

 

 

 

 

 

 

 

 

 

Income tax expense

 

(12,357)

 

(1,623)

 

(14,698)

 

(2,143)

 

 

 

 

 

 

 

 

 

Profit before minority interests

 

54,075

 

7,104

 

74,992

 

10,933

Minority interests

 

(17,187)

 

(2,258)

 

(14,872)

 

(2,168)

 

 

 

 

 

 

 

 

 

Net income

 

36,888

 

4,846

 

60,120

 

8,765

 

 

 

 

 

 

 

 

 

Net income per share – basic

 

1.59

 

0.21

 

2.62

 

0.38

 

 

 

 

 

 

 

 

 

Net income  per share – diluted

 

1.50

 

0.20

 

2.62

 

0.38

 

 

 

 

 

 

 

 

 

Shares used in calculating basic net income per share

 

23,146,355

 

23,146,355

 

22,987,272

 

22,987,272

 

 

 

 

 

 

 

 

 

Shares used in calculating diluted net income per share

 

24,646,355

 

24,646,355

 

22,987,272

 

22,987,272

 

 

 

 

 

 

 

 

 

 CONSOLIDATED BALANCE SHEETS

(In thousands, except share data)

 

 

September 30,

 

June  30,

 

 

2007

2007

 

2008

2008

 

 

RMB

US$

 

RMB

US$

 

 

 

 

 

(unaudited)

(unaudited)

Assets

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

Cash and cash equivalents

 

162,314

21,663

 

334,660

48,791

Debt securities

 

133,968

17,880

 

12,574

1,833

Accounts receivable, net

 

2,750

367

 

123

18

Due from related parties

 

7,384

986

 

3,928

573

Advances to suppliers

 

1,029

137

 

9,310

1,357

Advances to growers

 

24,452

3,263

 

12,007

1,750

Inventories

 

449,207

59,952

 

391,691

57,105

Income tax recoverable

 

1,760

235

 

1,680

245

Prepaid expenses and other current assets

 

11,459

1,529

 

7,422

1,082

 

 

 

 

 

 

 

Total current assets

 

794,323

106,012

 

773,395

112,754

Land use rights, net

 

21,554

2,877

 

20,556

2,997

Plant and equipment, net

 

143,043

19,091

 

148,419

21,638

Equity investments

 

58,882

7,858

 

62,458

9,106

Goodwill

 

16,665

2,224

 

16,665

2,430

Due from related parties

 

7,325

978

 

5,574

813

Acquired intangible assets, net

 

43,057

5,746

 

44,281

6,456

Deferred income tax assets

 

12,828

1,712

 

21,248

3,098

Other assets

 

13,306

1,776

 

15,849

2,311

 

 

 

 

 

 

 

Total assets

 

1,110,983

148,274

 

1,108,445

161,603

 

 

 

 

 

 

 

Liabilities, minority interests and shareholders’ equity

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

Short-term borrowings and current portion of long-term borrowings

 

268,400

35,821

 

229,940

33,523

Accounts payable

 

14,365

1,917

 

25,916

3,778

Due to growers

 

17,811

2,377

 

68

10

Due to related parties

 

4,233

565

 

10,135

1,478

Advances from customers

 

82,187

10,970

 

130,915

19,086

Deferred revenues

 

23,238

3,101

 

3,280

478

Income tax payable

 

39,059

5,213

 

45,823

6,681

Other payables and accrued expenses

 

50,054

6,680

 

41,358

6,030

 

 

 

 

 

 

 

Total current liabilities

 

499,347

66,644

 

487,435

71,064

 

 

 

 

 

 

 

Long-term borrowings

 

1,880

251

 

940

137

Convertible notes, net of discount

 

173,669

23,178

 

172,290

25,119

Embedded derivatives-redemption feature

 

86,937

11,603

 

59,125

8,620

Other long-term liabilities

 

3,458

461

 

3,658

533

 

 

 

 

 

 

 

Total liabilities

 

765,291

102,137

 

723,448

105,473

Minority interests

 

48,775

6,510

 

52,615

7,671

Commitments and contingencies

 

 

 

 

 

 

Shareholders’ equity:

 

 

 

 

 

 

Preferred stock (no par value;1,000,000 shares authorized, none issued)

 

-  

-  

 

-

-

Common stock (no par value; 60,000,000 shares authorized, 22,974,059  shares issued and  outstanding as of September 30, 2007,   and 23,013,702 shares issued and  outstanding  as of June 30, 2008, respectively)

 

-  

-  

 

-  

-  

Additional paid-in capital

 

377,324

50,359

 

386,462

56,343

Retained earnings (deficit)

 

(41,404)

(5,526)

 

(26,421)

(3,852)

Treasury stock at cost (498,851 shares)

 

(29,377)

(3,921)

 

(29,377)

(4,283)

Accumulated other comprehensive gain (loss)

 

(9,626)

(1,285)

 

1,718

251

 

 

 

 

 

 

 

Total shareholders’ equity

 

296,917

39,627

 

332,382

48,459

 

 

 

 

 

 

 

Total liabilities, minority interests and shareholders’ equity

 

1,110,983

148,274

 

1,108,445

161,603


 
 

 

 

 

The news item on this page is copyright by the organization where it originated - Fair use notice

Other news from this source


Copyright © SeedQuest - All rights reserved